Literature DB >> 16845629

Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection.

Ravit Arav-Boger1, Catherine A Battaglia, Tiziana Lazzarotto, Liliana Gabrielli, Jian C Zong, Gary S Hayward, Marie Diener-West, Maria P Landini.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) is the most common congenital infection in humans. The effect of viral strains on the outcome of congenital CMV is debated. We evaluated whether UL144 polymorphisms in amniotic fluid from CMV-infected Italian women were associated with terminations of pregnancy, subsequent disease in their offspring, or viral load.
METHODS: The study was nested within a prenatal CMV program. We sequenced the UL144 gene from 66 amniotic-fluid samples, without knowledge of pregnancy outcome. We performed data analyses on 56 samples for which all information was available.
RESULTS: Genotype C was associated with termination of pregnancy (P=.03). Genotype B was associated with fewer terminations of pregnancy (P=.003). A possible association was found between genotype C and symptomatic disease in newborns (odds ratio, 8.81 [95% confidence interval, 0.48-164.02]; P=.05). There was no association between specific genotype and the viral load in amniotic fluid. Symptomatic newborns who had the most common UL144 genotype (B) were more likely to have higher viral loads than were asymptomatic infants (P=.003).
CONCLUSIONS: UL144 polymorphisms may be associated with the outcome of congenital CMV infection. Larger studies should be conducted to confirm this association, before genotype analysis can be used, along with other factors, in considering terminations of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845629     DOI: 10.1086/505427

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Authors:  Jens-Uwe Vogel; Jürgen Otte; Frank Koch; Hermann Gümbel; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2012-06-06       Impact factor: 3.402

Review 2.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

3.  Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?

Authors:  Mark R Schleiss
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

4.  High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination.

Authors:  Steven Sijmons; Kim Thys; Mirabeau Mbong Ngwese; Ellen Van Damme; Jan Dvorak; Marnix Van Loock; Guangdi Li; Ruth Tachezy; Laurent Busson; Jeroen Aerssens; Marc Van Ranst; Piet Maes
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

5.  Human cytomegalovirus UL144 is associated with viremia and infant development sequelae in congenital infection.

Authors:  Allison Waters; Jaythoon Hassan; Cillian De Gascun; Ghia Kissoon; Susan Knowles; Eleanor Molloy; Jeff Connell; William W Hall
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

6.  Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections.

Authors:  E Paradowska; M Studzińska; D Nowakowska; J Wilczyński; M Rycel; P Suski; Z Gaj; B Kaczmarek; Z Zbróg; Z J Leśnikowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

Review 7.  Strain Variation and Disease Severity in Congenital Cytomegalovirus Infection: In Search of a Viral Marker.

Authors:  Ravit Arav-Boger
Journal:  Infect Dis Clin North Am       Date:  2015-07-04       Impact factor: 5.982

Review 8.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

9.  CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

Authors:  John R Šedý; Ryan L Bjordahl; Vasileios Bekiaris; Matthew G Macauley; Brian C Ware; Paula S Norris; Nell S Lurain; Chris A Benedict; Carl F Ware
Journal:  J Immunol       Date:  2013-06-12       Impact factor: 5.422

10.  The use of artificial neural networks in prediction of congenital CMV outcome from sequence data.

Authors:  Ravit Arav-Boger; Yuval S Boger; Charles B Foster; Zvi Boger
Journal:  Bioinform Biol Insights       Date:  2008-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.